Stock Update (NYSE:ACT): Actavis Reports Exceptional Performance in First Quarter 2015 with 59% Increase in Net Revenue to $4.2 Billion and 23% Growth in Non-GAAP EPS to $4.30
May 11, 2015 at 06:30 AM EDT
[PR Newswire] – DUBLIN, May 11, 2015 /PRNewswire/ — Actavis plc (NYSE: ACT) today reported continued exceptional performance with net revenue increasing 59 percent to $4.23 billion for the quarter ended March 31, . . . → Read More: Stock Update (NYSE:ACT): Actavis Reports Exceptional Performance in First Quarter 2015 with 59% Increase in Net Revenue to $4.2 Billion and 23% Growth in Non-GAAP EPS to $4.30 Similar Articles: Stock Update: Actavis plc (NYSE:ACT) – Actavis and Medicines360 Announce FDA Approval of LILETTA™ (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Three Years Company Update (NYSE:ACT): (OFFICIAL)-UPDATE 1-Actavis’ superbug antibiotic gets U.S. approval (Feb. 25) Stock Update (NYSE:ACE): ACE Aviation reports third quarter results and provides an update on its liquidation process
